Bringing Procurement Into a Healthcare Evaluation at the Right Time

Commercial discovery in healthcare includes the customer’s procurement process, but price should not be the only question. An account executive can ask when procurement participates, what information it requires, and how the business case is reviewed. This respects the buyer’s process while keeping value criteria connected to workflow and governance.

In a fictional meeting, director Alma says, “Procurement will get involved later.” Devon replies, “That makes sense. So I can plan accurately, what triggers their involvement, and what materials do they usually need from a business owner?” Alma says, “They need scope, security review, and budget approval.” Devon answers, “I will keep those as dependencies in the evaluation plan. Who should confirm the budget path when the workflow and review criteria are clearer?”

Devon has not asked the director to reveal confidential pricing or commit to a purchase. He has learned the sequence and a future owner. If terms are discussed, he should use approved commercial materials and involve the proper internal reviewer for any exception.

Practice a discovery call in which the buyer repeatedly says, “later.” Ask a neutral sequencing question each time. The final recap should include the procurement trigger, required materials, business owner, and next date for revisiting the commercial path.